Montana to receive 2nd round of COVID-19 antibody treatments

HELENA – The state of Montana is getting a second round delivery of Federal Drug Administration (FDA) approved COVID-19 antibody treatments.

Regeneron’s antibody therapeutic, casirivimab and imdevimab, is used to treat non-hospitalized or mildly to moderately symptomatic people over the age of 12-years in danger of advancing to hospitalization or severe symptoms.

According to a release from the Office of Sen. Daines, Montana is receiving 150 vials of the Regeneron casirivimab and imdevimab cocktail, one treatment per vial. In addition, Montana is also getting a fourth shipment of Eli Lilly’s antibody therapy this week, and 260 vials of bamlanivimab, one treatment per vial.